Current status of molecular markers for prognostication and outcome in invasive bladder cancer

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

(2011) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy

(2010) Luciana Schultz et al.   CANCER

Expression of cell cycle–related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder☆

(2010) Ramy F. Youssef et al.   HUMAN PATHOLOGY

Expression of pRb, p53, p16 and Cyclin D1 and Their Clinical Implications in Urothelial Carcinoma

(2010) Kyungji Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder Cancer

(2010) Miguel Alvarez-Múgica et al.   JOURNAL OF UROLOGY

Statistical consideration for clinical biomarker research in bladder cancer

(2010) Shahrokh F. Shariat et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy

(2009) Shahrokh F. Shariat et al.   JOURNAL OF UROLOGY

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

(2007) Shahrokh F. Shariat et al.   CANCER